Gain Therapeutics
Phase 1Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
Founded
2017
Focus
Small Molecules
About
Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
Funding History
3Total raised: $52.5M
Series B$40MFountain Healthcare PartnersMar 15, 2021
Series A$10MViva BioInnovatorJun 15, 2019
Seed$2.5MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2017
LocationLugano, Switzerland
StagePhase 1
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile